{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:49:32Z","timestamp":1791521372063,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cardfail.2026.08.019","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:06:33Z","timestamp":1788537993000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating Dipeptidyl Peptidase 3 Levels, an Antagonist of Angiotensin-(1\u20137), in Acute Heart Failure: Insights From the Pragmatic Urinary Sodium-based treatment algoritHm in Acute Heart Failure (PUSH-AHF) trial"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0480-724X","authenticated-orcid":false,"given":"STIJN","family":"LEGTENBERG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KARINE","family":"SANTOS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IRIS E.","family":"BELDHUIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OLIVER","family":"HARTMANN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LARA E.E.C.","family":"ZONNEVELD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PETER","family":"VAN\u202fDER\u202fMEER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAN A.","family":"KRIKKEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WYBE","family":"NIEUWLAND","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DIRK J.","family":"VAN\u202fVELDHUISEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ADRIAAN A.","family":"VOORS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KEVIN","family":"DAMMAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4910-9336","authenticated-orcid":false,"given":"JOZINE M.","family":"TER\u202fMAATEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2026.08.019_bib0001","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","article-title":"Global epidemiology of heart failure","volume":"21","author":"Khan","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0002","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0003","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/ejhf.2339","article-title":"Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology","volume":"23","author":"Moura","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0004","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ejhf.2158","article-title":"Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin\u2013angiotensin\u2013aldosterone system in patients with heart failure","volume":"23","author":"Boorsma","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0005","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/HYPERTENSIONAHA.123.21913","article-title":"Circulating dipeptidyl peptidase 3 modulates systemic and renal hemodynamics through cleavage of angiotensin peptides","volume":"81","author":"Picod","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0006","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40635-024-00638-3","article-title":"Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury","volume":"12","author":"Garcia","year":"2024","journal-title":"Intensive Care Med Exp"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0007","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ejhf.1601","article-title":"Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics","volume":"22","author":"Deniau","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0008","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1038\/s41591-023-02532-z","article-title":"Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial","volume":"29","author":"Maaten","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0009","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ejhf.2385","article-title":"Natriuresis-guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium-based treatment algoritHm in Acute Heart Failure (PUSH-AHF) trial","volume":"24","author":"Maaten","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0010","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1373\/jalm.2018.027995","article-title":"Novel methods for the quantification of dipeptidyl peptidase 3 (DPP3) concentration and activity in human blood samples","volume":"3","author":"Rehfeld","year":"2019","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0011","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jalm\/jfaf173","article-title":"Method validation of dipeptidyl peptidase 3 assay","volume":"11","author":"Donato","year":"2026","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13020333","article-title":"Biomarkers as prognostic predictors and therapeutic guide in critically ill patients: clinical evidence","volume":"13","author":"M\u00e9ndez Hern\u00e1ndez","year":"2023","journal-title":"J Pers Med"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0013","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13054-021-03471-2","article-title":"Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study","volume":"25","author":"Blet","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0014","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s13054-025-05545-x","article-title":"Targeting high circulating dipeptidyl peptidase 3 in circulatory failure","volume":"29","author":"Picod","year":"2025","journal-title":"Crit Care"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0015","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1111\/febs.16429","article-title":"The emerging role of dipeptidyl peptidase 3 in pathophysiology","volume":"290","author":"Malovan","year":"2023","journal-title":"FEBS J"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0016","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.3390\/jcm14217459","article-title":"One enzyme, many faces: the expanding role of DPP3 in cardiovascular and critical care","volume":"14","author":"Zakynthinos","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0017","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.bja.2021.11.021","article-title":"High plasma dipeptidyl peptidase 3 levels are associated with mortality and organ failure in shock: results from the international, prospective and observational FROG-ICU cohort","volume":"128","author":"Deniau","year":"2022","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0018","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1093\/eurheartj\/ehad545","article-title":"Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes","volume":"44","author":"Wenzl","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0019","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cardfail.2024.03.014","article-title":"High circulating dipeptidyl peptidase 3 predicts mortality and need for organ support in cardiogenic shock: an ancillary analysis of the ACCOST-HH trial","volume":"31","author":"Picod","year":"2025","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.974035","article-title":"DPP3: from biomarker to therapeutic target of cardiovascular diseases","volume":"9","author":"Ye","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0021","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(17)31071-1","article-title":"Heart failure","volume":"390","author":"Metra","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0022","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ejhf.1600","article-title":"Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial","volume":"22","author":"Takagi","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132036","article-title":"Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure","volume":"406","author":"Espersen","year":"2024","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.00123","article-title":"Prognostic value of N-terminal pro-B-type natriuretic peptide and glomerular filtration rate in patients with acute heart failure","volume":"7","author":"Wang","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0025","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.3390\/molecules27093006","article-title":"Survey of dipeptidyl peptidase III inhibitors: from small molecules of microbial or synthetic origin to aprotinin","volume":"27","author":"Abrami\u0107","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.cardfail.2026.08.019_bib0026","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/ejhf.3718","article-title":"Targeting dipeptidyl peptidase 3 (DPP3) in extreme-critically ill patients with refractory shock: first-in-human report on the safety and efficacy of an anti-DPP3 antibody","volume":"27","author":"Jarczak","year":"2025","journal-title":"Eur J Heart Fail"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916426005178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916426005178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:03:23Z","timestamp":1791518603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916426005178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"alternative-id":["S1071916426005178"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2026.08.019","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating Dipeptidyl Peptidase 3 Levels, an Antagonist of Angiotensin-(1\u20137), in Acute Heart Failure: Insights From the Pragmatic Urinary Sodium-based treatment algoritHm in Acute Heart Failure (PUSH-AHF) trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2026.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}